No black box warning on record for Ocrevus Zunovo
As of the latest FDA labeling reviewed, Ocrevus Zunovo (OCRELIZUMAB AND HYALURONIDASE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ocrevus Zunovo medicine page for the complete safety profile.